RecruitingNCT07490132

Endoscopic Retrograde Cholangiopancreatography

Endoscopic Retrograde Cholangiopancreatography Patient Registry

Sponsor

Methodist Health System

Enrollment

100 participants

Start Date

Feb 1, 2026

Study Type

OBSERVATIONAL

Conditions

Gastro-Intestinal Disorder

Summary

The risk of post-endoscopic retrograde cholangiopancreatography(ERCP) pancreatitis(PEP) is influenced by patient and procedure-related factors. Strategies to decrease PEP(Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis) are of great importance.

Eligibility

Min Age: 15 Years

Inclusion Criteria1

Patients \>15 years Included in MDI's Registry Underwent ERCP between January 1, 2000 through December 31, 2025

Exclusion Criteria1

Patients \<15 years Patients in which cannulation was via a surgical anastomosis Patients in which cannulation was not attempted due to gastric outlet obstruction, the main papilla not found, or the minor papilla was not found will be excluded.

Print for Your Doctor

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERPatients undergoing ERCPs at Methodist Dallas Medical Center

The registry will include all patients who meet registry inclusion. Enrollment will terminate once 25 years of data are captured: January 1, 2000 through December 31, 2025.